Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study-Reference-Cited by-同舟云学术

Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study

Published:2012-01 Issue:1 Volume:14 Page:82-90
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Guazzi Marco¹,Vicenzi Marco¹,Arena Ross²

Affiliation:

1. Cardiopulmonary Unit; University of Milano, San Paolo Hospital; Via A. di Rudinì, 8 20142 Milano Italy

2. Department of Orthopaedics and Rehabilitation-Physical Therapy Program and Department of Internal Medicine-Division of Cardiology; University of New Mexico School of Medicine; Albuquerque NM USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association;Balady;Circulation,2010

2. Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation;Leite;J Am Coll Cardiol,2003

3. Oscillatory ventilation during exercise in patients with chronic heart failure: clinical correlates and prognostic implications;Corrà;Chest,2002

4. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence;Corra;Circulation,2006

5. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value;Guazzi;Am Heart J,2007

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary hypertension associated to left heart disease: Phenotypes and treatment;European Journal of Internal Medicine;2024-08

2. Inhibidores de la fosfodiesterasa 5 para el tratamiento de la insuficiencia cardiaca: revisión sistemática y metaanálisis de ensayos clínicos aleatorizados;Archivos de Cardiología de México;2024-07-17

3. Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial;Journal of the American Heart Association;2024-04-02

4. A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function;European Journal of Heart Failure;2024-04

5. Modulation of the nitric oxide/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment;Pharmacological Research;2023-10